Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR

112.8  +0.4 (+0.36%)

Fundamental Rating

6

Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 55 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BIM was profitable.
In the past year BIM had a positive cash flow from operations.
In the past 5 years BIM has always been profitable.
Each year in the past 5 years BIM had a positive operating cash flow.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

1.2 Ratios

With an excellent Return On Assets value of 7.73%, BIM belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
BIM has a better Return On Equity (10.63%) than 78.43% of its industry peers.
BIM's Return On Invested Capital of 8.96% is fine compared to the rest of the industry. BIM outperforms 78.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BIM is above the industry average of 8.18%.
Industry RankSector Rank
ROA 7.73%
ROE 10.63%
ROIC 8.96%
ROA(3y)9.53%
ROA(5y)9.22%
ROE(3y)13.8%
ROE(5y)14.08%
ROIC(3y)11.57%
ROIC(5y)11.82%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 10.81%, BIM is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
BIM's Profit Margin has declined in the last couple of years.
The Operating Margin of BIM (13.65%) is better than 74.51% of its industry peers.
BIM's Operating Margin has declined in the last couple of years.
The Gross Margin of BIM (55.72%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 13.65%
PM (TTM) 10.81%
GM 55.72%
OM growth 3Y-12.33%
OM growth 5Y-3.52%
PM growth 3Y-9.13%
PM growth 5Y-1.68%
GM growth 3Y-0.15%
GM growth 5Y0.81%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

7

2. Health

2.1 Basic Checks

BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BIM has more shares outstanding
BIM has a worse debt/assets ratio than last year.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

BIM has an Altman-Z score of 6.86. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.86, BIM belongs to the best of the industry, outperforming 92.16% of the companies in the same industry.
The Debt to FCF ratio of BIM is 3.57, which is a good value as it means it would take BIM, 3.57 years of fcf income to pay off all of its debts.
BIM's Debt to FCF ratio of 3.57 is fine compared to the rest of the industry. BIM outperforms 74.51% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that BIM is not too dependend on debt financing.
BIM has a Debt to Equity ratio of 0.10. This is amongst the best in the industry. BIM outperforms 86.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.57
Altman-Z 6.86
ROIC/WACC1.19
WACC7.51%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

A Current Ratio of 2.21 indicates that BIM has no problem at all paying its short term obligations.
BIM's Current ratio of 2.21 is fine compared to the rest of the industry. BIM outperforms 64.71% of its industry peers.
A Quick Ratio of 1.20 indicates that BIM should not have too much problems paying its short term obligations.
The Quick ratio of BIM (1.20) is better than 60.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.2
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

BIM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.54%.
Measured over the past 5 years, BIM shows a small growth in Earnings Per Share. The EPS has been growing by 6.76% on average per year.
BIM shows a small growth in Revenue. In the last year, the Revenue has grown by 2.85%.
The Revenue has been growing by 8.70% on average over the past years. This is quite good.
EPS 1Y (TTM)6.54%
EPS 3Y-4.07%
EPS 5Y6.76%
EPS Q2Q%33.49%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y5.63%
Revenue growth 5Y8.7%
Sales Q2Q%7.45%

3.2 Future

BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.42% yearly.
The Revenue is expected to grow by 8.15% on average over the next years. This is quite good.
EPS Next Y11.79%
EPS Next 2Y11.78%
EPS Next 3Y12.31%
EPS Next 5Y13.42%
Revenue Next Year7.49%
Revenue Next 2Y7.5%
Revenue Next 3Y7.62%
Revenue Next 5Y8.15%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.60, BIM can be considered very expensive at the moment.
64.71% of the companies in the same industry are more expensive than BIM, based on the Price/Earnings ratio.
BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.19, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 24.40, the valuation of BIM can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as BIM.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.37, BIM is valued at the same level.
Industry RankSector Rank
PE 32.6
Fwd PE 24.4
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than the industry average as 68.63% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BIM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 85.36
EV/EBITDA 18.01
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
BIM's earnings are expected to grow with 12.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.76
PEG (5Y)4.82
EPS Next 2Y11.78%
EPS Next 3Y12.31%

3

5. Dividend

5.1 Amount

BIM has a yearly dividend return of 0.77%, which is pretty low.
Compared to an average industry Dividend Yield of 2.50, BIM has a dividend in line with its industry peers.
With a Dividend Yield of 0.77, BIM pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

The dividend of BIM is nicely growing with an annual growth rate of 20.02%!
Dividend Growth(5Y)20.02%
Div Incr Years0
Div Non Decr Years6
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

BIM pays out 24.36% of its income as dividend. This is a sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP24.36%
EPS Next 2Y11.78%
EPS Next 3Y12.31%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (1/23/2025, 5:35:15 PM)

112.8

+0.4 (+0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2024-10-30
Earnings (Next)N/A N/A
Inst Owners20.73%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.35B
Analysts78
Price Target122.23 (8.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Yearly Dividend0.85
Dividend Growth(5Y)20.02%
DP24.36%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.48%
PT rev (3m)1.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 32.6
Fwd PE 24.4
P/S 3.51
P/FCF 85.36
P/OCF 26.99
P/B 3.45
P/tB 5.09
EV/EBITDA 18.01
EPS(TTM)3.46
EY3.07%
EPS(NY)4.62
Fwd EY4.1%
FCF(TTM)1.32
FCFY1.17%
OCF(TTM)4.18
OCFY3.7%
SpS32.16
BVpS32.68
TBVpS22.16
PEG (NY)2.76
PEG (5Y)4.82
Profitability
Industry RankSector Rank
ROA 7.73%
ROE 10.63%
ROCE 12.03%
ROIC 8.96%
ROICexc 9.56%
ROICexgc 13.78%
OM 13.65%
PM (TTM) 10.81%
GM 55.72%
FCFM 4.11%
ROA(3y)9.53%
ROA(5y)9.22%
ROE(3y)13.8%
ROE(5y)14.08%
ROIC(3y)11.57%
ROIC(5y)11.82%
ROICexc(3y)13.89%
ROICexc(5y)13.87%
ROICexgc(3y)22.31%
ROICexgc(5y)23.43%
ROCE(3y)15.5%
ROCE(5y)15.82%
ROICexcg growth 3Y-22%
ROICexcg growth 5Y-8.85%
ROICexc growth 3Y-18.45%
ROICexc growth 5Y-4.35%
OM growth 3Y-12.33%
OM growth 5Y-3.52%
PM growth 3Y-9.13%
PM growth 5Y-1.68%
GM growth 3Y-0.15%
GM growth 5Y0.81%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.57
Debt/EBITDA 0.52
Cap/Depr 144.59%
Cap/Sales 8.88%
Interest Coverage 250
Cash Conversion 65.65%
Profit Quality 38.03%
Current Ratio 2.21
Quick Ratio 1.2
Altman-Z 6.86
F-Score6
WACC7.51%
ROIC/WACC1.19
Cap/Depr(3y)358.73%
Cap/Depr(5y)270.32%
Cap/Sales(3y)8.6%
Cap/Sales(5y)8.97%
Profit Quality(3y)53.51%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)6.54%
EPS 3Y-4.07%
EPS 5Y6.76%
EPS Q2Q%33.49%
EPS Next Y11.79%
EPS Next 2Y11.78%
EPS Next 3Y12.31%
EPS Next 5Y13.42%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y5.63%
Revenue growth 5Y8.7%
Sales Q2Q%7.45%
Revenue Next Year7.49%
Revenue Next 2Y7.5%
Revenue Next 3Y7.62%
Revenue Next 5Y8.15%
EBIT growth 1Y4.34%
EBIT growth 3Y-7.4%
EBIT growth 5Y4.87%
EBIT Next Year62.06%
EBIT Next 3Y26.65%
EBIT Next 5Y20.84%
FCF growth 1Y-59.94%
FCF growth 3Y-29.47%
FCF growth 5Y-9.18%
OCF growth 1Y-28.3%
OCF growth 3Y-8.57%
OCF growth 5Y2.19%